Delving into the Latest Updates on Rentschler Biotechnologie GmbH with Synapse

概览

关联

1

项与 Rentschler Biotechnologie GmbH 相关的药物

Interferon beta-1a(Rentschler)

靶点

IFNAR

作用机制

IFNAR激动剂 [+1]

在研机构-

原研机构

Rentschler Biotechnologie GmbH

在研适应症-

非在研适应症

多发性硬化症

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

100 项与 Rentschler Biotechnologie GmbH 相关的临床结果

登录后查看更多信息

0 项与 Rentschler Biotechnologie GmbH 相关的专利（医药）

登录后查看更多信息

12

项与 Rentschler Biotechnologie GmbH 相关的文献（医药）

2011-12-01·BMC Proceedings

Application of hydrocyclones for continuous cultivation of SP-2/0 cells in perfusion bioreactors: Effect of hydrocyclone operating pressure

Article

作者: Elsayed, Elsayed A ; Wagner, Roland

Background Hydrocyclones (HCs) have been recently extensively evaluated for their application in the separation of mammalian cells in perfusion bioreactors. The high centrifugal force derived within hydrocyclones is the key mechanism for cell separation inside such small-sized simple devices. This is usually accompanied by a very short residence time of the cells inside the separating equipment, usually not more than 0.2 s. Moreover, they have other specific characteristics, which highly recommend their application for the production of pharmaceutical products in perfusion cultivation bioreactors. They are characterized by their high performance, robustness, lack of movable parts, ease of in situ sterilization and suitability for cleaning-in-place processes.

Cell Technology for Cell Products

Repeated Batch Fermentation Using a Viafuge Centrifuge

作者: Peter Schlenke ; Ralf Fehrenbach ; Kurt Russ ; Hans Hofer ; Maya Kuchenbecker ; Harald Huchler

Fusion proteins with toxic activity

作者: Schmidt, Stefan R.

A review.This paper describes the different concepts of targeted cell killing therapy based on fusion proteins.Fusion proteins can contribute heavily in generating novel combinations of targeting moieties and toxic mols.Fusion proteins give new options by allowing novel combinations of well-proven mols. or integrating novel activities.

100 项与 Rentschler Biotechnologie GmbH 相关的药物交易

登录后查看更多信息

100 项与 Rentschler Biotechnologie GmbH 相关的转化医学

登录后查看更多信息